GAIN THERAPEUTICS INC

NASDAQ: GANX (Gain Therapeutics, Inc.)

Last update: 4 days ago, 3:49PM

2.62

0.28 (11.97%)

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Bearish Mixed
Biotechnology (Global) Bearish Mixed
Stock Gain Therapeutics, Inc. Bullish Bearish

Analyst Consensus

Strong Sell
Sell
Neutral
Buy
Strong Buy

3 Buy

Avg. Price @ Call: 3.25

Similar Stocks

Stock Market Cap DY P/E P/B
-
BBIO 5 B - - -
AGIO 2 B - - 2.67
ABCL 1 B - - 0.950
ARQT 924 M - - 8.87
ALLO 524 M - - 1.09

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson’s disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. The company derives revenues from collaboration and licensing agreements.

Sector Healthcare
Industry Biotechnology
Investment Style Small Value

Ownership

Name Date Shares Held
Prelude Capital Management, Llc 31 Dec 2023 58,100
52 Weeks Range
2.00 - 5.33
Price Target Range
6.00 - 9.00
High 9.00 (Oppenheimer, 243.51%) Buy
9.00 (HC Wainwright & Co., 243.51%) Buy
Median 9.00 (243.51%)
Low 6.00 (Chardan Capital, 129.01%) Buy
Average 8.00 (205.34%)
Total 3 Buy
Firm Date Target Price Call Price @ Call
HC Wainwright & Co. 15 May 2024 9.00 (243.51%) Buy 2.62
25 Apr 2024 9.00 (243.51%) Buy 3.07
Oppenheimer 23 Apr 2024 9.00 (243.51%) Buy 3.39
Chardan Capital 27 Mar 2024 6.00 (129.01%) Buy 3.73

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No data